Trial Profile
Infliximab Use in Fistulizing Crohn's Disease: Impact on Health Care Resources
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 10 May 2022
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme; Schering-Plough
- 16 Jul 2008 New trial record.